<DOC>
	<DOCNO>NCT00305396</DOCNO>
	<brief_summary>A prospective , single center , open-label , randomized trial Thymoglobulin induction sirolimus , prednisone , mycophenolate mofetil versus Thymoglobulin induction tacrolimus , prednisone , mycophenolate mofetil non-HLA identical living decease donor kidney transplant recipient .</brief_summary>
	<brief_title>Calcineurin Inhibitor Avoidance With Thymoglobulin Sirolimus Kidney Transplantation</brief_title>
	<detailed_description>Calcineurin inhibitor-associated nephrotoxicity may exacerbate chronic allograft nephropathy reduce long-term kidney graft survival . Complete avoidance calcineurin inhibitor may improve graft function measure serum creatinine calculate GFR improve long-term outcome follow kidney transplantation . We conduct prospective , randomize , single-center study compare sirolimus versus tacrolimus kidney transplantation . Primary cadaver non-HLA identical living donor recipient randomize receive either sirolimus 5 mg QD ( target level 8-12 ng/ml ) tacrolimus 0.075 mg/kg BID ( target level 8-12 ng/ml ) . All patient also receive Thymoglobulin 1.5 mg/kg x 4 dos , mycophenolate 1 gm BID , prednisone . Main outcome measure patient graft survival , biopsy-proven acute rejection , serum creatinine , hyperlipidemia , post-transplant diabetes , surgical wound complication .</detailed_description>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Primary cadaver nonHLA identical living donor kidney transplant . HIV HCV Pregnancy Age &lt; 18 year Malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>Kidney transplantation</keyword>
	<keyword>immunosuppression</keyword>
	<keyword>sirolimus</keyword>
	<keyword>Thymoglobulin</keyword>
</DOC>